Exact Mass: 506.05007780000005
Exact Mass Matches: 506.05007780000005
Found 45 metabolites which its exact mass value is equals to given mass value 506.05007780000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cefditoren
C19H18N6O5S3 (506.05007780000005)
Cefditoren is only found in individuals that have used or taken this drug. It is a third-generation cephalosporin antibiotic for oral use. It is commonly marketed under the trade name Spectracef by Cornerstone BioPharma.The bactericidal activity of cefditoren results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cefditoren is stable in the presence of a variety of b-lactamases, including penicillinases and some cephalosporinases. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
(3R,4S,5S,6S)-6-[4-Chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
Phosphoaminophosphonic acid-adenylate ester
C10H17N6O12P3 (506.01173120000004)
Dimethylellagic acid glucuronide
4-(Perfluorooctyl)-2-methyl-2-butanol
C13H11F17O (506.0538399999999)
(S)-METHYL 2-AMINO-3-(3,5-DICHLORO-4-((2-PHENYLBENZO[D]OXAZOL-7-YL)METHOXY)PHENYL)PROPANOATE HYDROCHLORIDE
C24H21Cl3N2O4 (506.05668360000004)
2-Naphthalenecarboxylicacid,4-[(3-carboxy-4-hydroxy-1-naphthalenyl)phenylmethylene]-1,4-dihydro-1-oxo-,sodium salt (1:2)
3,3-Diethyl-9-methylthiacarbocyanine iodide
C22H23IN2S2 (506.03473479999997)
(S)-3,3-Bis(4-chlorophenyl)-[1,1-binaphthalene]-2,2-diol
(R)-3,3-Bis(4-chlorophenyl)-[1,1-binaphthalene]-2,2-diol
Lead,bis(N,N-diethylcarbamodithioato-kS,kS)-, (T-4)-
C10H22N2PbS4 (506.04321819999996)
Phosphoaminophosphonic acid-adenylate ester
C10H17N6O12P3 (506.01173120000004)
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-Amino-2-deoxyadenosine 5-(tetrahydrogen triphosphate)
C10H17N6O12P3 (506.01173120000004)
(2S,3S,4S,5R)-6-[4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
9-{5-O-[(R)-Hydroxy{[(R)-Hydroxy(Phosphonoamino)phosphoryl]oxy}phosphoryl]-Alpha-L-Arabinofuranosyl}-9h-Purin-6-Amine
C10H17N6O12P3 (506.01173120000004)
(3R,4S,5S,6S)-6-[4-Chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
[[(2R,3R,4S,5S)-5-(6-aminopurin-9-yl)-3,4-dihydroxypyrrolidin-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate
C10H17N6O12P3 (506.01173120000004)
[3-bromo-5-thiophen-2-yl-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinyl]-(3,4-dihydro-2H-quinolin-1-yl)methanone
C21H14BrF3N4OS (506.00237300000003)
2-[[[[[5-[(4-Chloro-1-pyrazolyl)methyl]-2-furanyl]-oxomethyl]amino]-sulfanylidenemethyl]amino]-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid ethyl ester
3-(N-formyl-L-methionyl)-AMP
An L-methionine derivative that is the ester obtained by formal condensation of the carboxy group of N-formyl-L-methionine with the 3-hydroxy group of AMP.
Cefditoren
C19H18N6O5S3 (506.05007780000005)
A broad spectrum, third-generation cephalosporin antibiotic with (Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. Generally administered as its orally absorbed pivaloyloxymethyl ester prodrug, it is used for the treatment of mild to moderate infections caused by susceptible strains of microorganisms in acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, pharyngitis/tonsillitis, and uncomplicated skin and skin-structure infections. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
methyl 4,10'-dihydroxy-7-methoxy-5,8,9'-trioxo-3',4'-dihydro-3h-spiro[naphtho[2,3-b]furan-2,2'-pyrano[3,2-g]isochromene]-7'-carboxylate
7-({2-oxo-3-phenylcyclohepta[b]furan-7-yl}disulfanyl)-3-phenylcyclohepta[b]furan-2-one
5-(6-carboxy-2,3,4-trihydroxyphenoxy)-2-(5-carboxy-2,3-dihydroxyphenoxy)-3,4-dihydroxybenzoic acid
(4s,18r)-4,7-dimethyl-18-[2-(methylsulfanyl)ethyl]-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),7,9,12(23),14,16,19(22)-nonaene-2,9,16-triol
C20H22N6O4S3 (506.08646120000003)
(4s,18s)-4,7-dimethyl-18-[2-(methylsulfanyl)ethyl]-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),7,9,12(23),14,16,19(22)-nonaene-2,9,16-triol
C20H22N6O4S3 (506.08646120000003)
4,7-dimethyl-18-[2-(methylsulfanyl)ethyl]-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),7,9,12(23),14,16,19(22)-nonaene-2,9,16-triol
C20H22N6O4S3 (506.08646120000003)